This statement from Locust Walk left me with the impression that there may be one or more deals for IPIX to consider that LW has been negotiating, and possibly hinging on positive results of the labs testing of Brilacidin.
"Here at Locust Walk, we have a unique view into the strategic implications of COVID-19 on the fortunes of our industry’s most innovative companies. ..We have compiled a list of recommendations by company type for management teams and boards to consider."
Market Data 
Markets 
AI
